Europe Nutraceutical Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Europe Nutraceutical Market Trends and Insights

Aging population boosting functional intake

Europe’s aging population is increasing the demand for nutraceuticals that support cognitive health, bone strength, and heart health. As of January 2024, Europe’s overall population was estimated at 449.3 million, with over 21.6% aged 65 and older, according to the European Union^{[1]Source: European Union, "Population Structure and Ageing", ec.europa.eu}. With 1 in 6 Europeans dying from noncommunicable diseases before the age of 70, as per PubMed Central, as of May 2025, policymakers are encouraging preventive nutrition through subsidies to lower long-term healthcare costs^{[2]Source: PubMed Central, "From Inertia to Impact: Delivering Real Solutions For Non-Communicable Diseases", pmc.ncbi.nlm.nih.gov}. This has led to a rise in products like omega-3 supplements for cholesterol control and collagen peptides for joint health, aimed at seniors focused on staying active as they age. Recent product launches in Europe have introduced advanced formulations that combine these functional ingredients to address the specific needs of older adults. Companies focusing on senior health in their product development benefit from supportive policies, such as VAT reductions on medically targeted supplements and faster European Food Safety Authority (EFSA) approvals for health claims related to aging.

Rising consumer focus on preventive health and wellness nutrition

The European nutraceutical market is growing as more people focus on preventive health and wellness. This shift has increased demand for products that help prevent chronic diseases and support overall health. Consumers are looking for supplements and functional foods that boost immunity, improve digestion, increase energy, and promote well-being. According to the World Health Organization, by 2025, 8.9 million more people in Germany are expected to experience better health, reflecting a broader trend of health awareness across Europe^{[3]Source: World Health Organization, "Germany: Health Data Overview For The Federal Republic of Germany", data.who.int}. At Vitafoods Europe 2024, a leading industry event, companies showcased innovative products to meet these needs. For example, Evonik launched AvailOm, an omega-3 powder with Boswellia extract for joint health, and IN VIVO BIOTICS, a synbiotic solution to enhance gut health and immunity. These developments highlight the market’s focus on creating effective and convenient nutraceutical products that align with the growing interest in preventive health.

Obesity and weight-management concerns

Obesity and weight management are major health challenges in Europe, leading governments to implement various measures to address the issue. These include sugar taxes, clear front-of-pack nutritional labeling, and reforms in school meal programs to reduce the consumption of high-calorie foods. According to the World Population Review 2025, Russia has the highest obesity rate in Europe at 30.3%^{[4]Source: World Population Review, "European Obesity Rates by Country 2025", worldpopulationreview.com}. In response, consumers are increasingly relying on nutraceuticals to support their weight management goals. Companies are emphasizing European Food Safety Authority (EFSA)-approved claims related to weight control to differentiate their products from general wellness supplements. Pharmacies are creating specialized sections focused on anti-obesity solutions, offering a combination of measurement tools and clinically validated supplements. This growing focus on targeted solutions reflects the rising demand for effective and science-backed products to combat obesity and promote healthier lifestyles across the region.

Rising demand for clean-label and natural products

Consumers in Europe are increasingly looking for clean-label and natural nutraceutical products due to growing awareness about ingredient transparency and a preference for healthier, minimally processed options. They want products without artificial additives, preservatives, or synthetic ingredients, choosing those with simple, natural components that fit a healthy lifestyle. This shift has pushed manufacturers to update existing products and create new ones that highlight organic certifications, natural extracts, and eco-friendly packaging. For instance, at Vitafoods Europe 2024, companies launched clean-label products like Naturacare’s Vital Extend, a bilayer tablet with natural energy-boosting ingredients, and SIRIO Pharma’s PureOrganix™ range, which includes organic gummies made with ingredients like evening primrose oil and flaxseed oil, catering to the growing demand for natural and transparent formulations.

Stringent European Food Safety Authority (EFSA) health-claim validation processes

The strict health-claim approval process by the European Food Safety Authority (EFSA) creates significant hurdles for the European nutraceutical market. Companies must undergo a lengthy approval process, often taking 3 to 5 years, which includes conducting expensive clinical trials to validate health claims. The updated European Regulation 2015/2283, effective from 2025, has introduced stricter rules, requiring detailed documentation of production processes. This has further extended approval timelines and increased the complexity of bringing new products to market. As a result, larger multinational companies with dedicated regulatory teams are better positioned to navigate these challenges. While the market continues to grow, the pace of innovation has slowed. Each time the European Food Safety Authority (EFSA) introduces new rules or updates existing ones, it creates uncertainty for product developers, making it harder for companies to plan and launch new products. 

High product development and compliance costs

Launching a new ingredient in the European nutraceutical market is both expensive and time-consuming due to strict regulatory requirements. Companies must conduct toxicology studies, follow good manufacturing practices (GMP), and ensure compliance with detailed labeling rules. For example, in the Netherlands, the supplement-notification system has a few tiers, with high-risk products requiring safety evaluations similar to those needed for novel-food approvals. These complex and costly processes often force smaller companies to depend on contract manufacturers, which limits the growth of niche and artisanal brands. This has led to increased consolidation in the industry, as larger companies with more resources dominate the market. Investors are now focusing on how efficiently companies manage regulatory costs, such as the expense of obtaining approved health claims. This highlights how regulatory compliance plays a critical role in shaping competition and overall market trends.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Product Type: Functional Foods Hold Lead as Supplements Accelerate

Functional Foods lead the European nutraceutical market in 2025, holding a 36.12% share. The popularity of fortified cereals, probiotic dairy drinks, and protein-enriched bakery products drives this dominance. These items benefit from strong visibility in supermarkets, reduced sugar content, and high consumer loyalty. Fiber-fortified breakfast items and slow-digesting proteins remain household staples, while confectionery brands include plant sterols and omega-3s to cater to healthier snacking trends. Lactose-free specialty dairy drinks with probiotics further strengthen their position by addressing digestive health needs across all age groups.

Dietary Supplements are expected to grow the fastest, with a 6.68% CAGR through 2031, significantly contributing to the European nutraceutical market size during the forecast period. This growth is fueled by precise dosing, tele-nutrition services, and condition-specific products like enzyme blends for digestion or botanicals for menopause relief. Personalized daily sachets improve adherence and customer retention, while clean-label sports-nutrition capsules attract a broader audience beyond athletes. As e-pharmacy regulations tighten in the region, brands offering clinically backed products in convenient formats are well-positioned to gain market share in both physical and online stores.

By Source: Plant-Based Ingredients Dominate, Microbial Path Gains Momentum

Plant-based ingredients made up 54.05% of the European nutraceutical market share in 2025, driven by the region’s strong history with botanical extracts, herbal remedies, and fruit-based antioxidants. Consumers associate plant-based products with safety and sustainability, encouraging retailers to highlight eco-friendly labels and farm-to-table stories. Established suppliers use vertical integration and fair-trade certifications to ensure a steady supply of raw materials, while manufacturers combine different botanicals to create products targeting immunity, sleep, and metabolism. Examples like collagen from citrus peel and fermented soy isoflavones show how even traditionally animal-based or synthetic ingredients are shifting to plant-based options, helping maintain their leading position.

Microbial-based production is expected to grow at the fastest rate, with a 6.92% CAGR by 2031, making precision fermentation a key driver of the European nutraceutical market growth. Fermentation-based ingredients like riboflavin, resveratrol, and new postbiotic peptides avoid agricultural challenges, meet clean-label requirements, and reduce carbon footprints, appealing to environmentally conscious consumers. Collaborations between ingredient manufacturers and biotech startups have cut production costs compared to traditional methods, making these products more affordable. European Food Safety Authority (EFSA) approvals for fermented bioactives further validate this approach, attracting investments for developing new strains and boosting their use in supplements and fortified foods.

By Distribution Channel: Supermarkets Stay Anchor While E-Commerce Surges

Supermarkets/Hypermarkets remained the leading sales channel, holding 38.11% of the European nutraceutical market share in 2025. This dominance is due to high customer traffic, dedicated wellness sections, and loyalty programs that combine functional foods with supplements. In-store pharmacists and dietitians guide customers on European Food Safety Authority (EFSA)-approved claims, building trust during purchases. Private-label products, priced lower than national brands, attract budget-conscious buyers, while prominent placement of immunity shots and protein bars makes these items regular purchases. Some stores are even testing refill stations for vitamin gummies, showcasing innovation in physical retail.

Online Retail Stores are expected to grow at a 7.12% CAGR through 2031, increasing their share in the European nutraceutical market. Simplified compliance tools now allow products to be listed across countries in minutes. E-commerce platforms use AI-based quizzes and subscription offers to boost sales and retain customers, while fast urban delivery expands access to chilled probiotics. Features like QR codes and blockchain tracking help address concerns about counterfeit products, encouraging more purchases of premium items. As cross-border logistics improve under the European Union Digital Services Act, online stores will continue to gain market share, especially among younger consumers who prefer the convenience of shopping on their phones.

Geography Analysis

In 2025, Germany accounted for 19.22% of the European nutraceutical market share, driven by its strong focus on clinical testing and adherence to strict quality standards. These factors make German products highly appealing to health-conscious and cautious consumers. The country also complies with rigorous European Food Safety Authority (EFSA) requirements, ensuring product safety and reliability. German companies actively collaborate with partners across Europe, sharing research and expertise. This commitment to quality and innovation has built a strong reputation for Germany, positioning it as a key leader in the European nutraceutical market.

The United Kingdom is the fastest-growing market, with a projected CAGR of 7.38% through 2031. Since Brexit, the United Kingdom has been quicker to approve new foods and adapt labeling regulations, giving it an advantage in the market. Local brands are focusing on innovative products like gummies for cognitive health and beverages for stress relief, which align with growing consumer interest in mental and physical well-being. This adaptability and focus on evolving health needs have positioned the United Kingdom as a dynamic and rapidly expanding market for nutraceuticals.

Southern Europe offers diverse growth opportunities in the nutraceutical market. Italy leads in per-capita supplement spending, driving demand for premium anti-aging products. Spain incorporates functional foods into its Mediterranean diet, promoting items like olive-oil-based spreads and fiber-enriched gazpacho. France combines its culinary traditions with expertise in beauty products, boosting the popularity of nutricosmetics such as collagen supplements for skin health. These regional trends highlight the unique consumer preferences and growth potential across Southern Europe.

Regulatory Landscape

In Europe, food supplements are primarily governed under the EU framework led by Directive 2002/46/EC, which harmonizes rules for vitamins and minerals and sets out positive lists of permitted vitamins (Annex I) and permitted mineral sources (Annex II). Labeling obligations require clear nutrient content and use directions (for example, recommended daily dose and related warnings), and products are not permitted to claim prevention, treatment, or cure of disease within this framework.

Regulatory requirements remain dynamic due to periodic updates to the Directive annexes via Commission measures, with amendments published in 2024 and 2025 that require ongoing compliance monitoring across portfolios and SKUs. For cross-border commercialization, Regulation (EU) 2019/515 on mutual recognition supports market access for goods lawfully marketed in one Member State, but companies still need to manage country-specific notification and enforcement practices where EU harmonization is incomplete, particularly for borderline products and risk-managed categories.

Market Opportunities and Future Outlook

A key commercial whitespace is opening around regulatory harmonization of vitamin and mineral Maximum Permitted Levels (MPLs): the European Commission timetable points to a public consultation in Q3 2026, with a legal act targeted for Q1 2028. This creates near-term demand for reformulation toolkits, portfolio audits, and evidence packs that can be reused across multiple EU markets, particularly for high-velocity vitamins/minerals and fortified functional foods that currently face different national limits.

Innovation and operating-model opportunities are also coming from science-led differentiation and manufacturing modernization. EFSA novel food opinions published in December 2025, including an opinion on egg membrane collagen peptides for use in supplements for adults at a maximum dose of 500 mg, demonstrate a pathway for companies to develop premium, condition-specific formats under a clearer safety narrative. In parallel, European food-and-drink industry initiatives (for example, FoodDrinkEurope workstreams on net-zero pathways and processing upgrades, and technology roadmaps such as the ENOUGH project guidelines and Atlantic Area agrifood roadmaps) support investments in energy-efficient processing, electrification of heat, and digital product information, which can reduce compliance friction while improving speed-to-market for functional ingredients and finished nutraceutical products.